Can levetiracetam (Keppra) cause emotional changes in a child taking 2 ml twice daily, and what is the recommended approach for weaning off the medication?

Can Levetiracetam (Keppra) Cause Emotional Changes in Children?

Yes, levetiracetam can absolutely cause emotional and behavioral changes in children, including irritability, aggression, anxiety, hostility, and mood swings—these are well-documented adverse effects that occur in a significant minority of pediatric patients. 1, 2

Understanding the Behavioral Side Effects

Levetiracetam-induced behavioral changes are not uncommon and represent one of the most clinically significant adverse effects limiting its use in pediatric populations:

• Behavioral adverse effects occur in approximately 10-15% of pediatric patients, manifesting as irritability, hostility, aggression, anxiety, agitation, depression, and emotional lability 1, 3
• These symptoms typically emerge within the first 4 weeks of treatment initiation or following dose increases, though they can occur at any point during therapy 1, 3
• The FDA drug label specifically warns that levetiracetam may cause "changes in behavior (e.g., aggression, agitation, anger, anxiety, apathy, depression, hostility, and irritability)" 1
• In controlled pediatric trials, nervousness occurred in 10% of levetiracetam-treated patients versus 2% on placebo, personality disorder in 8% versus 1%, agitation in 6% versus 1%, and emotional lability in 6% versus 4% 1

The severity can range from mild mood changes to acute, severe behavioral abnormalities requiring immediate medication discontinuation 3, 4.

---

How to Safely Wean Off Levetiracetam

Levetiracetam should be tapered gradually over 2-4 weeks minimum, reducing the dose by approximately 25% every 5-7 days, with close monitoring for seizure recurrence and withdrawal symptoms. 1, 2

Specific Weaning Protocol for a Child on 2 mL BID

The exact tapering schedule depends on the concentration of your liquid formulation (typically 100 mg/mL), but here is the general approach:

• Week 1: Reduce one dose by 25-50% (e.g., if taking 2 mL twice daily, reduce to 1.5 mL in morning, 2 mL at night, or 1 mL morning and 2 mL night depending on tolerability) 1
• Week 2: Reduce both doses proportionally (e.g., 1 mL twice daily if tolerating well) 1
• Week 3: Continue gradual reduction (e.g., 0.5 mL twice daily) 1
• Week 4: Final taper to discontinuation (e.g., 0.5 mL once daily for several days, then stop) 1

Never discontinue levetiracetam abruptly, as this increases the risk of breakthrough seizures and potential status epilepticus 1, 2.

Critical Monitoring During the Taper

• Assess for seizure recurrence weekly during the taper and for 4-8 weeks after complete discontinuation, as this is the highest-risk period 1
• Monitor behavioral symptoms closely—paradoxically, some children experience worsening irritability or mood changes during withdrawal, while others show rapid improvement 3, 4
• If behavioral symptoms were the reason for discontinuation, expect improvement within days to 1-2 weeks after dose reduction or discontinuation, as levetiracetam has a relatively short half-life (5-7 hours in children) 5, 3
• If seizures increase during the taper, immediately return to the previous stable dose and consult with the prescribing physician about alternative antiepileptic options 1

---

Important Clinical Considerations

When Behavioral Changes Require Immediate Action

• Severe aggression, acute hostility, or dangerous behavior warrants immediate dose reduction or discontinuation, even if this means a faster taper under close medical supervision 3, 4
• Suicidal thoughts or self-harm ideation require emergency psychiatric evaluation, as all antiepileptic drugs carry a boxed warning for increased suicide risk 1
• One case report documented a teenage patient who developed "sudden, severe behavioral abnormalities and aggression following increases in his levetiracetam dosing," with symptoms resolving rapidly after return to baseline dosing 3

Alternative Management Strategies

If behavioral side effects are problematic but seizure control is good:

• Dose reduction rather than complete discontinuation may eliminate behavioral symptoms while maintaining seizure control 3, 4
• Slower titration schedules (increasing by smaller increments over longer intervals) can minimize behavioral adverse effects in susceptible patients 3
• Consider switching to an alternative antiepileptic drug with a more favorable behavioral profile if levetiracetam cannot be tolerated even at lower doses 2, 4

Common Pitfalls to Avoid

• Do not assume all behavioral changes are "just the child's personality"—levetiracetam-induced behavioral changes are a recognized adverse effect requiring clinical intervention 1, 3
• Do not taper faster than 25% reductions every 5-7 days unless there is a compelling safety reason (e.g., severe aggression), as rapid discontinuation increases seizure risk 1
• Do not restart levetiracetam at the previous full dose if behavioral symptoms led to discontinuation—if rechallenge is necessary, start at a much lower dose and titrate very slowly 3

---

Expected Timeline for Behavioral Symptom Resolution

• Mild to moderate irritability or mood changes typically improve within 3-7 days of dose reduction 3
• Severe behavioral symptoms (aggression, hostility) often resolve within 1-2 weeks of discontinuation, correlating with the drug's elimination half-life 5, 3
• If behavioral symptoms persist beyond 2-3 weeks after complete discontinuation, consider alternative explanations (underlying psychiatric condition, other medications, psychosocial stressors) 3